Biocorrx Inc Revenue Growth Rates (BICX), Current and Historic Growth - CSIMarket
CSIMarket
 


Biocorrx Inc   (BICX)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

BICX's Revenue Growth by Quarter and Year

Biocorrx Inc 's Revenue results by quarter and year




BICX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.09
1st Quarter March 0.21
FY 0.30

BICXs Annual Revenue
Biocorrx Inc 's Revenue in the fiscal year 2025 $ 0.80 millions
Biocorrx Inc 's Revenue in the fiscal year 2024 $ 0.01 millions
Biocorrx Inc 's Revenue in the fiscal year 2023 $ 0.09 millions
Biocorrx Inc 's Revenue in the fiscal year 2022 $ 0.21 millions
Biocorrx Inc 's Revenue in the fiscal year 2021 $ 0.05 millions




BICX Revenue second quarter 2026 Y/Y Growth Comment
Biocorrx Inc reported drop in Revenue in the second quarter 2026 by -51.13% to $ 0.09 millions, from the same quarter in 2025.
The fall in the second quarter 2026 Biocorrx Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 184.55%.

Looking into second quarter 2026 results within Healthcare Facilities industry 43 other companies have achieved higher Revenue growth. While Biocorrx Inc ' s Revenue meltdown of -51.13% ranks overall at the positon no. 3746 in the second quarter 2026.




BICX Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - - - -75 %
3rd Quarter September - - - -88.89 %
2nd Quarter June -51.13 % - - 0 %
1st Quarter March 61.54 % - - 100 %
FY   - - - -

Financial Statements
Biocorrx Inc 's second quarter 2026 Revenue $ 0.09 millions BICX's Income Statement
Biocorrx Inc 's second quarter 2025 Revenue $ 0.18 millions Quarterly BICX's Income Statement


BICX Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - - - 100 %
3rd Quarter September - 255.56 % - -50 %
2nd Quarter June -58.11 % 38.46 % - -50 %
1st Quarter March - - - -50 %
FY (Year on Year)   - - - -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #520
Overall #3746

Revenue Y/Y Growth Statistics
High Average Low
4306.38 % 184.55 % -100 %
(Dec 31 2022)   (Jun 30 2024)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #520
Overall #3746
Revenue Y/Y Growth Statistics
High Average Low
4306.38 % 184.55 % -100 %
(Dec 31 2022)   (Jun 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Biocorrx Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
967.13 % 36.25 % -100 %
(Jun 30 2011)  


BICX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Biocorrx Inc disclosed fall in Revenue from the first quarter by -58.11% to $ 0.09 millions, from $ 0.21 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.

Within Healthcare Facilities industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Biocorrx Inc 's Revenue growth quarter on quarter, overall rank is 3611.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #43
Healthcare Sector #532
Overall #3611
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #43
Healthcare Sector #532
Overall #3611
Revenue Q/Q Growth Statistics
High Average Low
967.13 % 36.25 % -100 %
(Jun 30 2011)  


BICX's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Biocorrx Inc disclosed fall in Revenue from the first quarter by -58.11% to $ 0.09 millions, from $ 0.21 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.

Within Healthcare Facilities industry 42 other companies have achieved higher Revenue quarter on quarter growth. While Biocorrx Inc 's Revenue growth quarter on quarter, overall rank is 3611.


Biocorrx Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.79 $ 0.88 $ 0.80 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -10.29 % 9.99 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1396 # 1396 # 0 # 0 # 2741


Cumulative Revenue growth Comment


Biocorrx Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 241
S&P 500 # 1396
Cumulative Revenue growth Comment


Biocorrx Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 241
S&P 500 # 1396




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BICX's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Biocorrx Inc Revenue Growth Rates (BICX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biocorrx Inc (CIK 1443863).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001477932-26-005041
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biocorrx Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.